Hypercholesterolemia and tissue-specific differential mRNA expression of type-1 5'-iodothyronine deiodinase under different selenium status in rats

Biological Research

Volumn 39, Issue 2, 2006, Pages 307-319

  Dhingra, Sanjiv ^a   Bansal, Mohinder P ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

5' DI; Cholesterol; Hypercholesterolemia; RT PCR; Selenium

Indexed keywords

CHOLESTEROL; LIOTHYRONINE; MESSENGER RNA; SELENIUM; SELENOPROTEIN; THYROXINE; THYROXINE DEIODINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; DIET SUPPLEMENTATION; ECTOPIC THYROID GLAND; ENZYME ACTIVITY; ENZYME REGULATION; GENE EXPRESSION; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; LIOTHYRONINE SYNTHESIS; LIPID METABOLISM; LIVER; MALE; NONHUMAN; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SELENIUM DEFICIENCY; THYROID GLAND;

ANIMALIA;

EID: 33746598130     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602006000200013     Document Type: Article

References (36)

1. ÁLVAREZ L, HERNÁNDEZ S, MARTÍNEZ-DE-MENA R, KOLLIKER-FRERS R, OBREGON MJ, KLEIMAN DE PISAREV DL (2005) The role of type I and type II 5′ deiodinases on hexachlorobenzene - induced alteration of the hormonal thyroid status. Toxicology 207: 349-362
2. ARTHUR JR, NICOL F, BECKETT GJ (1991) Hepatic iodothyronine deiodinase: The role of selenium. Biochem J 272: 537-540
3. ARTHUR JR, NICOL F, BACKETT GJ (1993) Selenium deficiency, thyroid hormone metabolism, and thyroid hormone deiodinases. Am J Clin Nutr 57: 236-239
4. BACKETT GJ, BEDDOWS SE, MORRICE PC, NICOL F, ARTHUR JR (1987) Inhibition of hepatic deiodination of thyroxine caused by selenium deficiency in rats. Biochem J 248: 443-447
5. BEECH SG, WALKER SW, BECKETT GJ, ARTHUR JR, NICOL F, LEE D (1995) Effect of selenium depletion on thyroidal type-1 iodothyronine deiodinase activity in isolated human thyrocytes, rat thyroid and liver. Analyst 120: 827-31
6. BEHNE D, HILMERT H, SCHIED H, GESSNER H, ELGER W (1988) Evidence for specific selenium target tissues and new biologically important selenoproteins. Biochem Biophys Acta 966: 12-21
7. BEHNE D, KYRIAKOPOULOS A, MEINHOLD H, KOHRLE J (1990) Identification of type-1 iodothyronine 5′-deiodinase as a selenoenzyme. Biochem Biophys Res Commun 173: 1143-1149
8. BERMANO G, NICOL F, DYER JA, SUNDE RA, BECKETT GJ, ARTHUR JR, HESKETH JE (1995) Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem J 311: 425-430
9. BERRY MJ, KATES AL, LARSEN PR (1990) Thyroid hormone regulates type I deiodinase messenger RNA in rat liver. Mol Endocrinol 4: 743-748
10. BERRY MJ, BANU L, LARSEN PR (1991) Type-1 iodothyronine deiodinase is a selenocysteine containing enzyme. Nature 349: 438-440
11. BRENT GA (1994) The molecular basis of thyroid hormone action. New Eng J Med 331: 847-853
12. BURK RF (1987) Production of selenium deficiency in the rat. Methods Enzymol 143: 307-313
13. DHINGRA S, SINGH U, BANSAL MP (2003) Protective role of selenium status on T3/T4 kinetics in rats under hyperlipidemia. Ind J Biochem Biophys 40: 260-264
14. DHINGRA S, SINGH U, BANSAL MP (2004) Effect of selenium depletion and supplementation on the kinetics of Type-I 5′-iodothyronine deiodinase and T3/T4 in rats. Biol Trace Ele Res 97: 95-104
15. DHINGRA S, BANSAL MP (2005) Attenuation of LDL receptor gene expression by selenium deficiency during hypercholesterolemia. Mol Cell Biochem (in press)
16. FRANK N, SOJKA JE, LATOUR MA (2004) Effect of hypothyroidism on the blood lipid response to higher dietary fat intake in mares. J Animal Sci 82: 2640-2646
17. GREEN WL (1978) Metabolism of thyroid hormones by rat thyroid tissue in vitro. Endocrinology 103: 826-837
18. GROSS M, OERTEL M, KOHRLE J (1995) Differential selenium-dependent expression of type I 5′-deiodinase and glutathione peroxidase in the porcine epithelial kidney cell line LLC-PK1. Biochem J 306: 851-855
19. HASUNUMA R, OGAWI T, KAWANISKA Y (1982) Fluorimetric determination of selenium in nanogram amounts in biological materials using 2,3-diaminonapthalene. Anal Biochem 26: 242-245
20. HUANG K, LIU H, CHEN Z, XU H (2002) Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. Atherosclerosis 162: 137-144
21. KANG BPS, MEHTA U, BANSAL MP (2000) Hyperlipidemia and type-I 5′-monodeiodinase activity: Regulation by selenium supplementation. Ind J Biochem Biophys 7: 183-187
22. KIMURA Y, YAMADA K, SAKAI T, MISHIMA K, NISHIMURA H, MATSUMOTO Y, SINGH M, YOSHIKAI Y (1998) The regulatory role of heat shock protein 70-reactive CD4+ T cells during rat listeriosis. Int Immunol 10: 117-130
23. KOHRLE J (1999) The trace element selenium and the thyroid gland. Biochimie 527-533
24. LEE O, MOON J, CHUNG Y (2003) The relationship between serum selenium levels and lipid profiles in adult women. J Nutr Sci Vitaminol (Tokyo) 49: 397-404
25. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ (1951) Protein measurement with Folin-phenol reagent. J Biol Chem 193: 265-275
26. MICHALOPOULOU G, ALEVIZAKI M, PIPERINGOS G, MITSIBOUNAS D, MANTZOS E, ADAMOPOULOS P, KOUTRAS DA (1998) High serum cholesterol levels in persons with "high-normal" TSH levels: should one extend the definition of subclinical hypothyroidism. Eur J Endocrinol 138: 141-145
27. NAPOLI R, BIONDI B, GUARDASOLE V MATARAZZO M, PARDO F, ANGELINI V, FAZIO S, SACCA L (2001) Impact of hyperthyroidism and its correction on vascular reactivity in humans. Circulation 104: 3076-3080
28. PAGLIA DE, VALENTINE WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 170: 158-168
29. PARK KW, DAI HB, OJAMAA K, LOWENSTEIN E, KLEIN I, SELLKE FW (1997) The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Anal 85: 734-738
30. PELTON PD, PATEL M, DEMAREST KT (2005) Nuclear receptors as potential targets for modulating reverse cholesterol transport. Curr Topics Med Chem 265-282
31. PINGITORE A, LANDI P, TADDEI MC, RIPOLI A, L'ABBATE A, IRVASI G (2005) Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med 118: 132-136
32. SIEGMUND W, SPIEKER K, WEIKE AI, GIESSMANN T, MODESS C, DABERS T, KIRSCH G, SANGER E, ENGEL G, HAMM A O, NAUCK M, MENG W (2004) Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14: 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf) 60: 750-757
33. VANDER GEYTEN S, BYAMUNGU N, REYNS GE, KUHN ER, DARRAS VM (2005) Iodothyronine deiodinases and the control of plasma and tissue thyroid hormone levels in hyperthyroid tilapia (Oreochromis niloticus). J Endocrinol 184: 467-479
34. VERHOELST CH, DARRAS VM, DOULABI BZ, REYNS G, KUHN ER, VANDER GEYTEN S (2004) Type I iodothyronine deiodinase in euthyroid and hypothyroid chicken cerebellum. Mol Cel Endocrinol 214: 97-105
35. WASSEN FW, KLOOTWIJK W, KAPTEIN E, DUNCKER DJ, VISSER TJ, KUIPER GG (2004) Characteristics and thyroid state-dependent regulation of iodothyronine deiodinases in pigs. Endocrinology 145: 4251-4263
36. WOJCICKI J, ROZEWICKA L, WISZNIEWSKA BB, SAMOCHOWIEC L, JUWIAK S, KADLUBOWSKA D, TUSTANOWSKI S, JUZYSZYN Z (1991) Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 87: 9-16